arrow
D

Dominique L. Braun

University of Zurich
H指数:39
被引数:7,204

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to ‘Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study – A mixed-methods study’ [Journal of Clinical Epidemiology, 188 (2025) 111973]

勘误:‘在瑞士HIV队列研究中实施随机化知情同意以实现群组内试验——一项混合方法研究’ [临床流行病学杂志,188(2025)111973]

2025-11-200
OAAI
Safety of Bacillus Calmette-Guérin Vaccination and Impact on HIV-1 Latent Reservoir Size in People With Treated HIV-1 Infection

卡介苗接种的安全性及对接受治疗的HIV-1感染者潜伏病毒库大小的影响

2025-10-010
OAAI
Implementing a randomization consent to enable Trials within Cohorts (TwiCs) in the Swiss HIV Cohort Study – A mixed-methods study

在瑞士艾滋病队列研究(Swiss HIV Cohort Study)中实施随机化知情同意以实现队列内试验(TwiCs)——一项混合方法研究

2025-09-120
PREAI
Untargeted Metabolite Profile Associations With Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study

无靶向代谢物谱与体重指数、腰臀比以及抗逆转录病毒疗法的关联:来自>1300名HIV感染者的瑞士HIV队列研究

2025-09-010
OA
Leukocyte count and new-onset diabetes mellitus in people with HIV: A longitudinal study

白细胞计数和新发糖尿病在HIV感染者中的研究:一项纵向研究

2025-08-010
OAAI
Types of Myocardial Infarction in People With HIV in Switzerland

瑞士人群中HIV感染者的心肌梗死类型

2025-07-010
OAAI
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility survey

参与临床试验的意愿及对抗逆转录病毒疗法的期望:一项针对治疗经验丰富的HIV感染者进行的可行性调查

2025-06-080
OA
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial
2024-10-160
OAAI
Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study
2024-10-110
OAAI
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study

免疫功能受损人群对二价加强SARS-CoV-2疫苗的抗体和T细胞反应: COVERALL-3研究

2024-06-070
OAAI
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide (TAF) in People With Human Immunodeficiency Virus (HIV)
2024-04-1212
OAAI
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
2024-03-222
OAAI
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol
2024-03-190
OAAI
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

病毒和宿主因素与新型冠状病毒肺炎住院患者的死亡率相关

2024-02-206
OA
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study
2024-01-160
OAAI